- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 1, 2026 | 45.16M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 48.54M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 48.47M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 46.61M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 46.6M sh |
| Stock Repurchased | Q2 2026 · Mar 31, 2026 | $17.79M |
| Stock Repurchased | Q2 2026 · Mar 31, 2025 | $3.26M |
| Capex | Q2 2026 · Mar 31, 2026 | $2.98M |
| Capex | Q2 2026 · Mar 31, 2025 | $567K |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $7.07M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $14.31M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $47.5M |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $0 |
| Short Term Debt | Q2 2026 · Mar 31, 2026 | $2.5M |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $152.22M |
| Short Term Investments | Q2 2026 · Mar 31, 2026 | $8.4M |
| Short Term Investments | Q2 2026 · Sep 30, 2025 | $38.86M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $69.19M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $154.15M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $239.47M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $233.66M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $240.26M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $220.21M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $200.92M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $214.8M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $59.94M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $209.03M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $117.47M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $218.85M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $156.5M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $248.49M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $356.94M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $459.11M |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $0.20 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $0.25 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.20 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.10 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $0.21 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $0.27 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.20 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.10 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $12.24M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $23.32M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $10.1M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $22M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $7.57M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $14.94M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $9.77M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $18.09M |
| Net Income | Q2 2026 · Mar 31, 2026 | $9.54M |
| Net Income | Q2 2026 · Mar 31, 2026 | $12.31M |
| Net Income | Q2 2026 · Mar 31, 2025 | $9.15M |
| Net Income | Q2 2026 · Mar 31, 2025 | $4.54M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $13.55M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $18.99M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $11.37M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $8.29M |
| Revenue | Q2 2026 · Mar 31, 2026 | $54.84M |
| Revenue | Q2 2026 · Mar 31, 2026 | $99.09M |
| Revenue | Q2 2026 · Mar 31, 2025 | $51.93M |
| Revenue | Q2 2026 · Mar 31, 2025 | $89.18M |